JP2023511992A5 - - Google Patents

Info

Publication number
JP2023511992A5
JP2023511992A5 JP2022545423A JP2022545423A JP2023511992A5 JP 2023511992 A5 JP2023511992 A5 JP 2023511992A5 JP 2022545423 A JP2022545423 A JP 2022545423A JP 2022545423 A JP2022545423 A JP 2022545423A JP 2023511992 A5 JP2023511992 A5 JP 2023511992A5
Authority
JP
Japan
Prior art keywords
cldna
dna
nucleotide
nucleotides
modified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022545423A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023511992A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/052204 external-priority patent/WO2021152147A1/en
Publication of JP2023511992A publication Critical patent/JP2023511992A/ja
Publication of JP2023511992A5 publication Critical patent/JP2023511992A5/ja
Priority to JP2025137441A priority Critical patent/JP2025186257A/ja
Pending legal-status Critical Current

Links

JP2022545423A 2020-01-31 2021-01-29 修飾ヌクレオチドを用いた閉じた直鎖dna Pending JP2023511992A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025137441A JP2025186257A (ja) 2020-01-31 2025-08-21 修飾ヌクレオチドを用いた閉じた直鎖dna

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20382063.4 2020-01-31
EP20382063 2020-01-31
PCT/EP2021/052204 WO2021152147A1 (en) 2020-01-31 2021-01-29 Closed linear dna with modified nucleotides

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025137441A Division JP2025186257A (ja) 2020-01-31 2025-08-21 修飾ヌクレオチドを用いた閉じた直鎖dna

Publications (2)

Publication Number Publication Date
JP2023511992A JP2023511992A (ja) 2023-03-23
JP2023511992A5 true JP2023511992A5 (cg-RX-API-DMAC7.html) 2024-02-05

Family

ID=69713977

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022545423A Pending JP2023511992A (ja) 2020-01-31 2021-01-29 修飾ヌクレオチドを用いた閉じた直鎖dna
JP2025137441A Pending JP2025186257A (ja) 2020-01-31 2025-08-21 修飾ヌクレオチドを用いた閉じた直鎖dna

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025137441A Pending JP2025186257A (ja) 2020-01-31 2025-08-21 修飾ヌクレオチドを用いた閉じた直鎖dna

Country Status (8)

Country Link
US (1) US20230323343A1 (cg-RX-API-DMAC7.html)
EP (1) EP4097253A1 (cg-RX-API-DMAC7.html)
JP (2) JP2023511992A (cg-RX-API-DMAC7.html)
KR (1) KR20220133999A (cg-RX-API-DMAC7.html)
CN (1) CN115003829A (cg-RX-API-DMAC7.html)
AU (1) AU2021213927A1 (cg-RX-API-DMAC7.html)
CA (1) CA3164390A1 (cg-RX-API-DMAC7.html)
WO (1) WO2021152147A1 (cg-RX-API-DMAC7.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4083227A1 (en) * 2021-04-29 2022-11-02 4basebio, S.L.U. Linear dna with enhanced resistance against exonucleases
EP4124660A1 (en) * 2021-07-30 2023-02-01 4basebio, S.L.U. Linear dna with enhanced resistance against exonucleases and methods for the production thereof
WO2023023285A2 (en) 2021-08-19 2023-02-23 Twist Bioscience Corporation Methods and compositions relating to covalently closed nucleic acids
CN114075595B (zh) * 2021-11-22 2023-11-17 上海交通大学 甲基化检测组合物、试剂盒及方法
CN119095602A (zh) * 2022-02-10 2024-12-06 代码生物疗法公司 增强的dna树枝状聚合物及其使用方法
JP2025516638A (ja) * 2022-05-13 2025-05-30 フラッグシップ パイオニアリング イノベーションズ セブン,エルエルシー 二本鎖dna組成物及び関連する方法
CN115976138A (zh) * 2022-06-02 2023-04-18 宜明(苏州)细胞生物科技有限公司 新型闭合线性双链dna的体外制备技术
KR20250034991A (ko) 2022-08-16 2025-03-11 알데브론 엘엘씨 합성 환형 핵산 생산을 위한 무세포 방법
ES3062031T3 (cg-RX-API-DMAC7.html) * 2023-02-01 2026-04-08 4Basebio Uk Ltd
EP4410995A1 (en) * 2023-02-01 2024-08-07 4basebio, S.L.U. Linear dna with enhanced resistance against exonucleases and methods for the production thereof
WO2025034978A1 (en) * 2023-08-09 2025-02-13 Code Biotherapeutics, Inc. Enhanced dna dendrimers and methods of use thereof
EP4780983A1 (en) * 2023-09-18 2026-07-29 Intellia Therapeutics, Inc. Nuclease resistant double stranded dna product for non-viral delivery to a cell and methods of production thereof
WO2025096807A2 (en) * 2023-10-31 2025-05-08 Flagship Pioneering Innovations Vii, Llc Novel therapeutic dna forms
WO2025202929A1 (en) * 2024-03-29 2025-10-02 Pfizer Inc. Methods for producing nucleic acids
EP4663200A1 (en) * 2024-06-10 2025-12-17 CPTx GmbH Compositions and methods
US20260000702A1 (en) 2024-06-26 2026-01-01 Flagship Pioneering Innovations Vii, Llc Therapeutic circular dna forms
WO2026012450A1 (zh) * 2024-07-11 2026-01-15 石药集团中奇制药技术(石家庄)有限公司 一种非病毒载体介导的大片段dna定点敲入系统

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4373071A (en) 1981-04-30 1983-02-08 City Of Hope Research Institute Solid-phase synthesis of polynucleotides
JP4517061B2 (ja) * 2003-08-08 2010-08-04 独立行政法人産業技術総合研究所 ダンベル型dnaの効率的な製造方法
EP1716234B1 (de) * 2004-02-20 2013-10-02 Mologen AG Substituiertes, nicht-kodierendes nukleinsäuremolekül zur therapeutischen und prophylaktischen immunstimulation in menschen und höheren tieren
WO2006085664A1 (ja) 2005-02-10 2006-08-17 The University Of Tokyo ポリカチオン荷電性ポリマー及び核酸のキャリヤーとしての使用
ES2359058B1 (es) 2009-07-02 2012-03-27 Consejo Superior De Investigaciones Cient�?Ficas (Csic) Quimera de adn polimerasa del fago ph1 29.
GB2523187A (en) * 2014-02-18 2015-08-19 Mologen Ag Covalently closed non-coding immunomodulatory DNA construct
JP7058502B2 (ja) * 2014-04-11 2022-04-22 レッドボールト バイオサイエンシズ エルピー ゲノム適用および治療適用のための、核酸分子のクローン複製および増幅のためのシステムおよび方法
GB201418159D0 (en) * 2014-10-14 2014-11-26 Oxford Nanopore Tech Ltd Method
CN116732145A (zh) * 2016-08-16 2023-09-12 塔驰莱特Ip有限公司 闭合线性dna的生产
US11473090B2 (en) * 2017-05-16 2022-10-18 Helix Nanotechnologies, Inc. Linear covalently closed vectors and related compositions and methods thereof
WO2019101596A1 (en) * 2017-11-21 2019-05-31 Expedeon Ltd Methods and kits for amplification of double stranded dna

Similar Documents

Publication Publication Date Title
JP2005517427A5 (cg-RX-API-DMAC7.html)
JP2010525813A5 (cg-RX-API-DMAC7.html)
JP2022017453A5 (cg-RX-API-DMAC7.html)
JP2019517268A5 (cg-RX-API-DMAC7.html)
JP2006502694A5 (cg-RX-API-DMAC7.html)
JP2023504264A5 (cg-RX-API-DMAC7.html)
JP2005517452A5 (cg-RX-API-DMAC7.html)
JP2005517432A5 (cg-RX-API-DMAC7.html)
JP2018527013A5 (cg-RX-API-DMAC7.html)
JP2012502657A5 (cg-RX-API-DMAC7.html)
JP2005524393A5 (cg-RX-API-DMAC7.html)
JP2002531053A5 (cg-RX-API-DMAC7.html)
JP2005517430A5 (cg-RX-API-DMAC7.html)
JP2005517438A5 (cg-RX-API-DMAC7.html)
JP2008283975A5 (cg-RX-API-DMAC7.html)
JP2024107295A5 (cg-RX-API-DMAC7.html)
JP2006526394A5 (cg-RX-API-DMAC7.html)
JP2023553983A5 (cg-RX-API-DMAC7.html)
JP2021505129A5 (cg-RX-API-DMAC7.html)
JP2022524435A5 (cg-RX-API-DMAC7.html)
RU2020100919A (ru) СПОСОБ НОКАУТИРОВАНИЯ ГЕНА-МИШЕНИ В T-КЛЕТКЕ IN VITRO И crRNA, ПРИМЕНЯЕМАЯ В ДАННОМ СПОСОБЕ
JP2023521042A5 (cg-RX-API-DMAC7.html)
JP2023540177A5 (cg-RX-API-DMAC7.html)
Zain et al. Preferred site for initiation of RNA transcription by Escherichia coli RNA polymerase within the simian virus 40 DNA segment of the nondefective adenovirus-simian virus 40 hybrid viruses AD2+ ND1 and Ad2+ ND3
JP2022512264A5 (cg-RX-API-DMAC7.html)